WILLIAMS LAW GROUP, P.A.
2503 W. Gardner Ct.
Tampa FL 33611
Phone: 813-831-9348
Fax: 813-832-5284
e-mail: wmslaw@tampabay.rr.com
January 12, 2006
Mr. Scott Anderegg
United States Securities and Exchange Commission
Division of Corporation Finance
450 Fifth Street, N.W.
Washington, D.C. 20549-0408
Re: Majestic Oil & Gas, Inc.
Registration Statement on Form SB-2
File No. 333-125539
Dear Mr. Anderegg:
We have enclosed the above Amendment.
Responses to your comment letter dated September 22, 2005 are set forth in the
attached Table, with page number references to pages in the marked copy.
Thank you for your consideration.
Sincerely,
Michael T. Williams, Esq.
- --------------------------------------------------------------------------------
Comment Page[s] Explanation
Number
- --------------------------------------------------------------------------------
1. 32 Terms defined and explained
- --------------------------------------------------------------------------------
2. F-1 Pages renumbered
- --------------------------------------------------------------------------------
3. 3, 7 Language added
- --------------------------------------------------------------------------------
4. 3 Intention to file Form 8-A disclosed
- --------------------------------------------------------------------------------
5. 9 Risk revised and amount disclosed
- --------------------------------------------------------------------------------
6. 6 Revised to name Mr. Montalban
- --------------------------------------------------------------------------------
7. 6 Revised and shortened
- --------------------------------------------------------------------------------
8. 6, 38 Conflict and cost and profit issued addressed
- --------------------------------------------------------------------------------
9. 7 Language on page 43 eliminated. As disclosed here
and throughout: The selling shareholders cannot
acquire the shares underlying these warrants
until our shares are quoted on the OTC Bulletin
Board and will be sold thereafter at prevailing
market prices or privately negotiated prices.
Thus there will be no sales at different prices.
- --------------------------------------------------------------------------------
10. 7 Penny stock issues disclosed
- --------------------------------------------------------------------------------
11. 8 Disclosure revised
- --------------------------------------------------------------------------------
12. 9-15 Entire risk factor section revised in view of these
comments
- --------------------------------------------------------------------------------
13. Eliminated. See response to Comment 4 above
- --------------------------------------------------------------------------------
14. 16 Use of proceeds information added
- --------------------------------------------------------------------------------
15. 17 No affiliation disclosed
- --------------------------------------------------------------------------------
16. Not applicable
- --------------------------------------------------------------------------------
17. 20 Disclosure added in footnote 3
- --------------------------------------------------------------------------------
18. We understand and confirm our understanding
- --------------------------------------------------------------------------------
19. 25 Eliminated
- --------------------------------------------------------------------------------
20. 26 Revised
- --------------------------------------------------------------------------------
21. 26 Revised
- --------------------------------------------------------------------------------
22. 32 How price set disclosed
- --------------------------------------------------------------------------------
23. 28 Location of both wells in Lake Francis Prospect
disclosed
- --------------------------------------------------------------------------------
24. 33 Amount of time disclosed
- --------------------------------------------------------------------------------
25. 33 No federal land drilling disclosed
- --------------------------------------------------------------------------------
26. 31 Revised
- --------------------------------------------------------------------------------
27. 34 Trend information added
- --------------------------------------------------------------------------------
28. 35 Nine month comparison added
- --------------------------------------------------------------------------------
29. 36 Disclosure added
- --------------------------------------------------------------------------------
30. Eliminated
- --------------------------------------------------------------------------------
31. Eliminated
- --------------------------------------------------------------------------------
32. 34 Revised
- --------------------------------------------------------------------------------
33. 37-38 Disclosure added
- --------------------------------------------------------------------------------
34. 38 Date disclosed
- --------------------------------------------------------------------------------
35. 50 Dates disclosed
- --------------------------------------------------------------------------------
36. 40 Disclosure clarified
- --------------------------------------------------------------------------------
37. Financials updated
- --------------------------------------------------------------------------------
38. Financials revised per comment
- --------------------------------------------------------------------------------
39. Financials revised per comment
- --------------------------------------------------------------------------------
40. Financials revised per comment
- --------------------------------------------------------------------------------
41. Financials revised per comment
- --------------------------------------------------------------------------------
42. Financials revised per comment
- --------------------------------------------------------------------------------
43. Financials revised per comment
- --------------------------------------------------------------------------------
44. As per SFAS #128, Para. 17, in part, warrants will
have a dilutive effect only when the average price
market price per share of the common stock during
the period exceeds the exercise price of the
warrants (i.e., they are "in the money"). While the
Company showed a small profit for the year 2004,
the Company still has a very large accumulated
deficit and its equity is such that the market
price per share has not risen above the $0.25 per
share exercise price of the warrants. The Company
therefore believes the warrants are anti-dilutive
for that year.
- --------------------------------------------------------------------------------
45. Financials revised per comment
- --------------------------------------------------------------------------------
46. Financials revised per comment
- --------------------------------------------------------------------------------
47. The SFAS 69 disclosures have now been re-labeled as
"supplementary information"
- --------------------------------------------------------------------------------
48. 51-53 Revised and new undertakings required post 12-1-
2005 added
- --------------------------------------------------------------------------------
49. 53 Language added
- --------------------------------------------------------------------------------
50. 52 Language revised
- --------------------------------------------------------------------------------